Thyroid Cancer Detection by Ultrasound Molecular Imaging with SHP2-Targeted Perfluorocarbon Nanoparticles

Figure 1

The study drawn scheme. (a) Variant expression of SHP2 in thyroid cancer was assessed on normal and malignant thyroid tissues that were collected from patients undergoing biopsy or surgical operation. (b) SHP2-targeted nanoparticles were produced and tested in vitro and vivo.

(a)

(b)